Tesamorelin Injection

Tesamorelin is a highly potent growth polypeptide, composed of 44 amino acids and is analogous to the naturally occurring growth hormone releasing hormone (GHRH). Tesamorelin mainly acts by stimulating the GHRH receptors located in the pituitary gland. Once stimulated, these receptors produce and release growth hormones (GH) which then also lead to the synthesis of IGF-1. Both GH and IGF-1 stimulate lipolysis and metabolism of lipids in the body, especially the abdominal region. Tesamorelin is the first and only peptide treatment for HIV induced lipodystrophy and is the potential therapeutic agent in the treatment of HIV induced liver disor